Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Radient registers Onko-Sure patent in China, Japan

Radient Pharmaceuticals has registered patent applications for its non-invasive cancer blood test, Onko-Sure, in China and Japan.

Onko-Sure is a 96-well Enzyme-linked immunosorbent assay (ELISA) test kits used to detect and treat 19 different types of cancers.

Radient Pharmaceuticals chairman and CEO Douglas MacLellan said Japan and China are larger markets, where having patent protection improves their ability to forge productive distribution partnerships for their cancer test.